This patented innovative technology, short for "Co-cultured Cardiomyocytes-on-a-Chip," allows scientists to non-invasively track the contractility (or beating) of heart muscle cells. By mimicking the natural environment of heart tissue on a benchtop device, Coco Chip opens new doors for drug screening, evaluating cardiac treatments like pacemakers, and studying the progression of heart diseases in individuals from varying genetic backgrounds. These applications can lead to personalized treatment strategies and a better understanding of heart diseases in diverse groups.